
Regulators voted to cancel the previous years-old plan for cannabis consumption sites in favor of a new, faster approach.
Regulators voted to cancel the previous years-old plan for cannabis consumption sites in favor of a new, faster approach.
After the most recent cannabis legalization bill failed to pass the Senate, Governor Sununu issued a statement explaining how legalization could occur instead.
The cannabidiol (CBD) market reached a saturation level in recent years with products popping up around every corner—from the local gas station to the neighborhood market and more. How can consumers know which of those products are safe and reliably labeled? It is an unfortunate fact that there are bad products on the market, some that have no CBD at all despite label claims. Despite these bad actors, many companies are striving to do better and even set higher standards for the industry. For instance, Vantage Hemp Co. has made it their mission to go beyond current state requirements and produce pharmaceutical-grade CBD. Here, Deepank Utkhede, Chief Operating Officer at Vantage Hemp Co., discusses his role with the company and their goals to elevate this market to create a safe place for consumers and manufacturers.
Consumers want options, especially when purchasing products, and organic seems to be a popular selection. It makes sense really: people eat all organic foods, why wouldn’t you want your cannabis to be organic too? Organic items are widely available and can be purchased at any grocery store, farmers market, and online. Most people associate “organic” with healthy foods that were grown using safe and sustainable agricultural methods and fewer chemicals. Organic certified products are typically pricier compared to conventionally grown crops—this can be attributed to the cost of the organic certification from an accredited third party, required use of costly organic approved chemicals, special handling practices, potential lower yield, lack of government subsidies, and so on. With organic products being sold at a higher price than conventional products and with the high consumer demand for organic products, does this combination open the door to fraud?
The agent claimed he frequently used CBD for pain management, which contributed to the levels of THC found in a urinalysis.
Within the next few weeks, France will become the latest country to ban the substance hexahydrocannabinol (HHC).
A test of a small sample of products sold in the Twin Cities revealed amounts of THC past the legal limit.
Heading to Tennessee Governor Bill Lee’s desk, is a newly approved cannabis regulatory legislation, specifically for hemp-derived cannabinoids.
The cannabis industry has experienced rapid growth over the past few years with the legalization of both medical and recreational cannabis use in numerous countries and states in the US. As the industry expands, the need for effective packaging and proper labeling has become increasingly important to ensure consumer safety, brand recognition, and compliance with regulations. Let’s explore the significance of packaging and labeling in the cannabis industry and discuss the key considerations for businesses operating in this space.
Filmed onsite at Cannabis Science Conference Spring 2023, Kim Stuck, founder and CEO of Allay Consulting, shares her unique insights and experiences in the industry.
Workplace safety procedures help companies be the best they can be, especially when it comes to ensuring your staff goes home the same way they arrived. These are just a few ways to begin your safety journey!
In late March, the Wine & Spirits Wholesalers of America submitted a letter to congressional leadership expressing its support for cannabis legalization that uses regulatory frameworks similar to those of the alcohol industry.
This tutorial article outlines the key considerations that must be put in place when setting up a cannabis extraction facility.
This blog is in response to the January 26th, 2023 announcement from the Food and Drug Administration (FDA) in regards to regulatory oversight in the cannabidiol (CBD) market.
This article addresses the US Department of Agriculture’s hemp testing rules and what laboratories should know regarding hemp testing. The author provides a short tutorial for laboratories and includes a section how laboratory information management systems (LIMS) can help.
Currently in the life cycle of the cannabis industry, it is not obvious where the heavy metal regulatory landscape will end up. Clearly, the big four are not enough, but what is a realistic panel that reflects the real world of cannabinoid production?
Experts within the global cannabis and hemp industries discuss the importance of testing and regulations and sustainable measures that can reduce the sector’s environmental impact.
Creating a “culture of compliance” is a buzz phrase that you have probably heard before when speaking to regulators, lawmakers, auditors, and compliance consultants. At Allay Consulting, we have worked with a multitude of companies, and we have found that creating a compliance culture alone is not enough to keep your employees happy enough to follow all compliances. I would argue that creating a “culture of excellence” that includes compliance is the best way we have seen to mitigate risk and decrease revenue lost due to employee turnover and lack of employee engagement. This article is meant to encourage our industry to create a culture of excellence at the workplace. I hope our tips and hands-on experience shed light into creating the culture you want at your workplace.
The beginning of 2023 will be a huge step to the US’s legalized psilocybin industry! Oregon Psilocybin Services (OPS), a new section housed within the Oregon Health Authority (OHA), will begin accepting license applications January 2, 2023. Oregon’s legalization and implementation of regulations will take three years altogether—several years may seem too long for the legalized psilocybin roll out, but better late than never. This should give the department plenty of time to draft, edit, edit some more, then implement the nation’s first regulatory framework for psilocybin.
Psychedelics, also known as entheogens. Everyone has an opinion. From the superb kaleidoscope shapes, or making that concert even more memorable, or to digging a bit deeper within yourself for self-healing—entheogens can be a game changer. For some, these experiences are life changing, especially if it means improving well-being and life satisfaction. Thanks to many published clinical trials, the benefits of using entheogens such as psilocybin include reducing anxiety and depression, successful addiction interruption, post-traumatic stress disorder (PTSD) treatment, and many others. With increased awareness of the benefits of psilocybin and other entheogens, we are observing an acceptance of entheogens followed by decriminalization and future legalization.
Cannabis testing laboratories play an important role in ensuring consumer safety and quality throughout the industry. These laboratories face many challenges—from the variety of samples in the industry to changing regulations and testing requirements and everything in between. In this interview, Sarah Ahrens, Founder and CEO of True Labs for Cannabis LLC, explains her philosophy and approach behind building her cannabis analytical testing laboratory in New Jersey. She also covers current developments in the cannabis testing industry and what needs to be done to ensure it has a transparent and productive future that benefits producers and consumers alike.
Delta-8 and delta-10 have gained considerable traction over the past year. Although these cannabinoid isomers fall in an extreme grey area, consumers are driving up demand. They can be purchased in many different forms and are commonly found in vaping products, gummies, and tinctures. Since these isomers are commonly derived from hemp extract, many consumers see delta-8 and delta-10 as a lawful hemp-derived good that provides a psychoactive effect. Per a new stance from the federal government, vaping products with these isomers fall under the 2018 Farm Bill. Even with the Food and Drug Administration’s (FDA) stance regarding the 2018 Farm Bill exempting hemp from the Controlled Substances Act (CSA), the popular edible cannabinoid isomers are not automatically legal.
AC Braddock, the CEO of Eden Labs, shares a preview of the talk she plans to give at Cannabis Science Conference West as well as other industry insights.
In this interview, Abbey Roudebush, Director of Government Affairs for Americans for Safe Access (ASA), explains the goals of ASA and provides an in-depth analysis of their annual State of the States report.
In this article, regulatory requirements are explored as they are meant to create confidence that cannabis and cannabis-infused products are safe to use.